IR-Med Inc. received notice that Dr. Rom Eliaz would be resigning from his role as Chief Executive Officer to pursue personal interests. Dr. Eliaz's resignation will be effective as of April 30, 2022. Dr. Eliaz's resignation was not associated with or attributable to any disagreement with the Company or the Company's independent auditor, including without limitation, any matter relating to the Company's accounting principles or practices, financial statement disclosures, internal controls, management or operations.

In connection with his resignation, the Company agreed that Dr. Eliaz will continue to receive his salary and benefits under his employment agreement through August 31, 2022.